The Strategic Partnerships 2013 report is the first study to understand the value Strategic Partnerships provide to biopharmaceutical companies of all sizes. It also further defines the next-generation of Strategic Partnerships that advance and optimize clinical development.
Strategic Partnerships 2013
The PAREXEL® BioPharm Unit
A Focus on Service
Helping Clients Succeed
Improve health care by participating in clinical research. Provide your patients access to novel therapies.
Meeting critical development goals of small and mid-sized biopharmaceutical companies with aligned incentives, dedicated teams, and innovative study execution.
The chance to change the world with new treatment and cures. Contribute to life-saving advances and new treatments that are changing lives.